Quintero Rudolfo B, Urban Renata, Lathi Ruth B, Westphal Lynn M, Dahan Michael H
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Stanford University, Stanford, CA 94305-5317, USA.
Fertil Steril. 2007 Oct;88(4):879-85. doi: 10.1016/j.fertnstert.2006.11.166.
To compare pregnancy rates (PR) for letrozole and gonadotropins in individuals who failed to conceive with clomiphene citrate (CC).
Retrospective cohort study.
University reproductive center.
PATIENT(S): Individuals treated with letrozole or gonadotropins who failed to conceive with CC.
INTERVENTION(S): Controlled ovarian hyperstimulation (COH), transvaginal ultrasound, ovulation induction, IUI.
MAIN OUTCOME MEASURE(S): Pregnancy rates per cycle.
RESULT(S): Among patients who failed to conceive with at least three cycles of CC, gonadotropins had a higher PR per cycle than letrozole. Among individuals who failed to conceive with less than three cycles of CC and whose medications were changed because of thin uterine lining or intolerable side effects, average PR per cycle for letrozole and gonadotropin treatments were equivalent. All patients conceived within three stimulation cycles with either gonadotropins or letrozole.
CONCLUSION(S): In patients who failed to conceive with CC, gonadotropins have higher PR for ovulation induction than letrozole. However, PR were high enough with letrozole to justify its use in this population of patients. Letrozole and gonadotropins should not be used for more than three cycles without a conception.
比较来曲唑和促性腺激素对枸橼酸氯米芬(CC)治疗后仍未受孕者的妊娠率(PR)。
回顾性队列研究。
大学生殖中心。
接受来曲唑或促性腺激素治疗且CC治疗未受孕者。
控制性卵巢刺激(COH)、经阴道超声检查、排卵诱导、宫腔内人工授精(IUI)。
每个周期的妊娠率。
在至少三个周期CC治疗仍未受孕的患者中,促性腺激素每个周期的PR高于来曲唑。在CC治疗少于三个周期且因子宫内膜薄或无法耐受副作用而更换药物的患者中,来曲唑和促性腺激素治疗的平均每个周期PR相当。所有患者使用促性腺激素或来曲唑在三个刺激周期内均受孕。
在CC治疗未受孕的患者中,促性腺激素诱导排卵的PR高于来曲唑。然而,来曲唑的PR足够高,足以证明其在这类患者中的应用合理性。来曲唑和促性腺激素在未受孕的情况下使用不应超过三个周期。